SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

GE and GlaxoSmithKline team up for oncology testing Working to standardize diagnostic testing

Boosting access to primary care Increasing amount of physicians is not the answer

Federal government weighs in on antibiotic resistance Issues national strategy and calls for alternative treatments

A protein can speed up recovery after radiation and chemo Shows promise in animal experiments

Patient engagement solutions market expected to soar Will hit $13.7 billion by 2019

Big data platform designed for new value-based model Helps physicians improve outcomes while reducing costs

Hospitals saving billions on charity care ACA may save expansion state hospitals up to $4.2 billion in 2014

FDA approves GE's new PET/CT Higher sensitivity and field-of-view

Consensys joins forces with Oncology Services International A strategic alliance among ISOs

Checking in with the first installed MEVION S250 Assessing nine months of single room proton therapy

Dr. Phillip Gray, lead author of the study
on prostate cancer patients
treated with proton therapy,
3-D CRT, and IMRT, during a briefing

Proton therapy's benefits for the treatment of prostate cancer on display at ASTRO 2012

by Loren Bonner , DOTmed News Online Editor
The American Society of Radiation Oncology's (ASTRO) annual meeting, held last week in Boston, was a testament to the growing body of evidence supporting proton beam therapy for the treatment of men with prostate cancer.

Several studies were presented at the conference that assessed prostate cancer patients' quality of life and toxicities following treatment with proton beam therapy. All of the studies reported favorable outcomes, especially for safeguarding men's bowel and urinary functions.

Story Continues Below Advertisement

SIUI introduces two ULTRACLOUD color Doppler systems - click for more info

The two new models provide premium imaging performance. Apogee 5500 is equipped with new 4D imaging tools which contribute to lifelike images and more reliable diagnosis while Apogee 1000 features lightweight laptop design



Quality of life

One of the larger data sets presented was a multi-institutional study of 1,090 men treated at the MD Anderson Proton Therapy Center, Scripps Proton Therapy Center, Loma Linda Medical Center, Massachusetts General Hospital, and the University of Florida Proton Therapy Institute. It found that patient-reported quality of life scores equaled healthy men. Patients, who averaged 65 years old, completed the Expanded Prostate Cancer Index Composite (EPIC) survey up to 10 years following proton beam therapy treatment. Prostate cancer patients scored 89.8 for urinary quality and 92.7 for bowel functions, compared with scores of 89.5 and 92.4, respectively, for healthy men. The survey used a scoring system of 1 (poor) to 100 (perfect).

Another study compared quality of life scores from prostate cancer patients who received proton beam therapy to those who were treated with two other common radiation therapy modalities: intensity modulated radiation therapy (IMRT) and 3-D conformal (3-D CRT). One of the main takeaways from this study, authors concluded, was that proton beam therapy appeared to be associated with better early bowel quality of life compared to 3D-CRT and IMRT. The study evaluated 123 patients treated with 3D-CRT from 1994-2000 at Harvard Affiliated Hospitals; 153 patients treated with IMRT from 2003-2006 at 9 hospitals; and 94 patients treated with proton beam therapy from 2004-2008 at Massachusetts General Hospital.

ProCure's findings

While all studies to date on the effectiveness of proton beam therapy treatment have been conducted at academic medical centers, the for-profit chain ProCure, which has been opening centers around the country, has also been compiling evidence for proton beam therapy. The first ProCure center opened in Oklahoma City in 2009, and from day one, it established a patient database and opened a registry study.

Dr. Sameer Keole, a radiation oncologist at ProCure Proton Therapy Center in Oklahoma City, presented results from 76 prostate cancer patients who were treated at the facility.

Continue reading Proton therapy's benefits for the treatment of prostate cancer on display at ASTRO 2012...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED